New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
Breast milk may have potential protective effects against SARS-CoV-2, say researchers

Breast milk may have potential protective effects against SARS-CoV-2, say researchers

JANUARY 29, 2024by Betty Zou,University of TorontoCredit: Pixabay/CC0 Public DomainThe COVID-19 pandemic was an especially harrowing time for pregnant people and new parents.The uncertainties ab
OB & GYN March 28,2024
Breast milk may have potential protective effects against SARS-CoV-2, say researchers

Breast milk may have potential protective effects against SARS-CoV-2, say researchers

JANUARY 29, 2024by Betty Zou,University of TorontoCredit: Pixabay/CC0 Public DomainThe COVID-19 pandemic was an especially harrowing time for pregnant people and new parents.The uncertainties ab
OB & GYN March 28,2024
New research finds half-cardio, half-strength training reduces cardiovascular disease risks

New research finds half-cardio, half-strength training reduces cardiovascular disease risks

by Iowa State UniversityStructured Graphical Abstract Effects of 1-year resistance, aerobic, or combined exercise training on cardiovascular disease (CVD) risk profile: the CardioRACE trial. Aero
Cardiovascular Diseases March 28,2024
New research finds half-cardio, half-strength training reduces cardiovascular disease risks

New research finds half-cardio, half-strength training reduces cardiovascular disease risks

by Iowa State UniversityStructured Graphical Abstract Effects of 1-year resistance, aerobic, or combined exercise training on cardiovascular disease (CVD) risk profile: the CardioRACE trial. Aero
Cardiovascular Diseases March 28,2024
Researchers find Boswellia, an extract of frankincense, shows anti-cancer activity in small trial

Researchers find Boswellia, an extract of frankincense, shows anti-cancer activity in small trial

JANUARY 11, 2024by Leslie Cantu,Medical University of South CarolinaMajor types of boswellic acids in B. serrate. Credit:Breast Cancer Research and Treatment(2024). DOI: 10.1007/s105
Oncology March 28,2024
Researchers find Boswellia, an extract of frankincense, shows anti-cancer activity in small trial

Researchers find Boswellia, an extract of frankincense, shows anti-cancer activity in small trial

JANUARY 11, 2024by Leslie Cantu,Medical University of South CarolinaMajor types of boswellic acids in B. serrate. Credit:Breast Cancer Research and Treatment(2024). DOI: 10.1007/s105
Oncology March 28,2024
A naturally-occurring molecule shows promise as effective first-line treatment for prostate cancer

A naturally-occurring molecule shows promise as effective first-line treatment for prostate cancer

JANUARY 5, 2024byNottingham Trent UniversityLive-cell cytotoxicity analysis shows that carnosine induces the death of PC346Flu1 (A) and TRAMP-C1 (B) cells. Carnosine inhibited cell growth in a d
Oncology March 28,2024
A naturally-occurring molecule shows promise as effective first-line treatment for prostate cancer

A naturally-occurring molecule shows promise as effective first-line treatment for prostate cancer

JANUARY 5, 2024byNottingham Trent UniversityLive-cell cytotoxicity analysis shows that carnosine induces the death of PC346Flu1 (A) and TRAMP-C1 (B) cells. Carnosine inhibited cell growth in a d
Oncology March 28,2024
Research team discovers potential Alzheimer's drug

Research team discovers potential Alzheimer's drug

FEBRUARY 6, 2024by University of Arkansas for Medical SciencesMolecular docking predicts a CLEAR DNA-binding region in ApoE4. a The DNA-binding region of ApoE4, as defined by molecular modeling. b The
Breakthroughs March 28,2024
Research team discovers potential Alzheimer's drug

Research team discovers potential Alzheimer's drug

FEBRUARY 6, 2024by University of Arkansas for Medical SciencesMolecular docking predicts a CLEAR DNA-binding region in ApoE4. a The DNA-binding region of ApoE4, as defined by molecular modeling. b The
Breakthroughs March 28,2024
New study suggests target steps per day for reduced risk of heart failure

New study suggests target steps per day for reduced risk of heart failure

by University at BuffaloCredit: Pixabay/CC0 Public DomainThe science is clear that movement is good for our bodies as we age. But just how much physical activity is beneficial for people over 60?
Cardiovascular Diseases March 28,2024
New study suggests target steps per day for reduced risk of heart failure

New study suggests target steps per day for reduced risk of heart failure

by University at BuffaloCredit: Pixabay/CC0 Public DomainThe science is clear that movement is good for our bodies as we age. But just how much physical activity is beneficial for people over 60?
Cardiovascular Diseases March 28,2024
Team develops a single-nucleus resolution atlas of white adipose tissue in different depots

Team develops a single-nucleus resolution atlas of white adipose tissue in different depots

FEBRUARY 5, 2024by Higher Education PressWorkflow to perform snRNA-seq of different WAT depots. The nuclei were derived from subcutaneous (S), epididymal (E), mesenteric (M), peri-nephritic (N), and p
Breakthroughs March 28,2024
Team develops a single-nucleus resolution atlas of white adipose tissue in different depots

Team develops a single-nucleus resolution atlas of white adipose tissue in different depots

FEBRUARY 5, 2024by Higher Education PressWorkflow to perform snRNA-seq of different WAT depots. The nuclei were derived from subcutaneous (S), epididymal (E), mesenteric (M), peri-nephritic (N), and p
Breakthroughs March 28,2024
Researchers halt progression of Parkinson's disease in mouse model

Researchers halt progression of Parkinson's disease in mouse model

NOVEMBER 14, 2023by Jacqueline Mitchell,Beth Israel Deaconess Medical CenterGeneration and characterization of Usp30 KO mice. a Schematic of gene targeting to generate the Usp30 KO mice. b Bar g
Breakthroughs March 28,2024
Researchers halt progression of Parkinson's disease in mouse model

Researchers halt progression of Parkinson's disease in mouse model

NOVEMBER 14, 2023by Jacqueline Mitchell,Beth Israel Deaconess Medical CenterGeneration and characterization of Usp30 KO mice. a Schematic of gene targeting to generate the Usp30 KO mice. b Bar g
Breakthroughs March 28,2024
Researchers find Zika virus is effective when used to treat a type of childhood cancer in mice

Researchers find Zika virus is effective when used to treat a type of childhood cancer in mice

JANUARY 9, 2024byNemours Children's Health SystemTransmission electron micrograph (TEM) of Zika virus. Credit: Cynthia Goldsmith/Centers for Disease Control and PreventionInjecting neuroblas
Breakthroughs March 28,2024
Researchers find Zika virus is effective when used to treat a type of childhood cancer in mice

Researchers find Zika virus is effective when used to treat a type of childhood cancer in mice

JANUARY 9, 2024byNemours Children's Health SystemTransmission electron micrograph (TEM) of Zika virus. Credit: Cynthia Goldsmith/Centers for Disease Control and PreventionInjecting neuroblas
Breakthroughs March 28,2024
AI tools better at predicting heart transplant rejection than standard clinical method, finds study

AI tools better at predicting heart transplant rejection than standard clinical method, finds study

by Emory UniversityCredit: Emory UniversityMore than 4,500 heart transplants were performed in the U.S. in 2023. While the lifesaving operation improves the quality of life and longevity for most
Cardiovascular Diseases March 28,2024
AI tools better at predicting heart transplant rejection than standard clinical method, finds study

AI tools better at predicting heart transplant rejection than standard clinical method, finds study

by Emory UniversityCredit: Emory UniversityMore than 4,500 heart transplants were performed in the U.S. in 2023. While the lifesaving operation improves the quality of life and longevity for most
Cardiovascular Diseases March 28,2024
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com